Talphera, Inc. (TLPH) - Latest Market Data

Price & Market Data

Price: $0.807

Daily Change: -$0.0106 / 1.31%

Daily Range: $0.80 - $0.848

Market Cap: $42,303,404

Daily Volume: 43,878

Performance Metrics

1 Week: -6.94%

1 Month: 9.00%

3 Months: 4.33%

6 Months: -35.78%

1 Year: 63.59%

YTD: -27.33%

About Talphera, Inc. (TLPH)

Essential market overview for Talphera, Inc. (TLPH). Current price: 0.807, daily change: -$0.0106 / 1.31%. Market cap: 42,303,404. All key performance metrics for a full analysis.

Company Details

Employees: 12

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Selected stocks

Synergy CHC Corp. (SNYR)

Expion360 Inc. (XPON)

Caesarstone Ltd. (CSTE)

Ucommune International Ltd (UK)

Snail, Inc. (SNAL)